{
    "title": "We Should at Least Be Able to Design Molecules That Dock Well. (arXiv:2006.16955v5 [q-bio.BM] UPDATED)",
    "abstract": "Designing compounds with desired properties is a key element of the drug discovery process. However, measuring progress in the field has been challenging due to the lack of realistic retrospective benchmarks, and the large cost of prospective validation. To close this gap, we propose a benchmark based on docking, a popular computational method for assessing molecule binding to a protein. Concretely, the goal is to generate drug-like molecules that are scored highly by SMINA, a popular docking software. We observe that popular graph-based generative models fail to generate molecules with a high docking score when trained using a realistically sized training set. This suggests a limitation of the current incarnation of models for de novo drug design. Finally, we propose a simplified version of the benchmark based on a simpler scoring function, and show that the tested models are able to partially solve it. We release the benchmark as an easy to use package available at https://github.com",
    "link": "http://arxiv.org/abs/2006.16955",
    "context": "Title: We Should at Least Be Able to Design Molecules That Dock Well. (arXiv:2006.16955v5 [q-bio.BM] UPDATED)\nAbstract: Designing compounds with desired properties is a key element of the drug discovery process. However, measuring progress in the field has been challenging due to the lack of realistic retrospective benchmarks, and the large cost of prospective validation. To close this gap, we propose a benchmark based on docking, a popular computational method for assessing molecule binding to a protein. Concretely, the goal is to generate drug-like molecules that are scored highly by SMINA, a popular docking software. We observe that popular graph-based generative models fail to generate molecules with a high docking score when trained using a realistically sized training set. This suggests a limitation of the current incarnation of models for de novo drug design. Finally, we propose a simplified version of the benchmark based on a simpler scoring function, and show that the tested models are able to partially solve it. We release the benchmark as an easy to use package available at https://github.com",
    "path": "papers/20/06/2006.16955.json",
    "total_tokens": 906,
    "translated_title": "我们至少应该能够设计出好的分子结合体",
    "translated_abstract": "设计具有所需特性的化合物是药物发现过程的关键元素。然而，由于缺乏现实的回顾性基准和前瞻性验证的高昂成本，衡量该领域的进展一直是具有挑战性的。为了弥补这一差距，我们提出了一个基于对接的基准测试，这是一种用于评估分子结合蛋白质的流行计算方法。具体而言，目标是生成得分高的药物样分子，这些药物属于SMINA，一种流行的对接软件。我们观察到，在使用真实大小的训练集进行训练后，流行的基于图形的生成模型无法生成具有高结合得分的分子。这表明了当前的模型在新型药物设计中存在局限性。最后，我们提出了基于简化评分函数的基准测试版本，并展示测试模型能够部分解决该问题。我们将该基准测试作为一个易于使用的软件包发布，可在 https://github.com 上获得。",
    "tldr": "该文提出了一个基于对接的基准测试来评估分子结合蛋白质的流行计算方法，探究了目前基于图形的生成模型在新型药物设计上的局限性，并提出了新的基准测试版本。",
    "en_tdlr": "The paper proposes a docking-based benchmark to evaluate the computational method for assessing molecule binding to a protein, explores the limitations of current graph-based generative models in de novo drug design, and suggests a new simplified benchmark version."
}